0% found this document useful (0 votes)
61 views6 pages

Hepatology Dewdrops-1-1

The document provides a comprehensive overview of various liver diseases, their symptoms, associated conditions, diagnostic methods, and treatment options. Key conditions discussed include Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Autoimmune Hepatitis, Non-Alcoholic Fatty Liver Disease (NAFLD), and Wilson's disease, among others. It also covers diagnostic tests, liver biopsy findings, and the implications of liver function tests in assessing liver damage and disease progression.

Uploaded by

Shakil
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
61 views6 pages

Hepatology Dewdrops-1-1

The document provides a comprehensive overview of various liver diseases, their symptoms, associated conditions, diagnostic methods, and treatment options. Key conditions discussed include Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Autoimmune Hepatitis, Non-Alcoholic Fatty Liver Disease (NAFLD), and Wilson's disease, among others. It also covers diagnostic tests, liver biopsy findings, and the implications of liver function tests in assessing liver damage and disease progression.

Uploaded by

Shakil
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 6

Hepatology dewdrops

 PBC (M rule):
 Lethargy followed by pruritus+ Middle aged female +Jaundice (cholestatic)+
Hyperpigmentation+ xanthoma+ Positive AMA(95%, initial test)+ Dyslipidemia
 Common association: Sjogren’s syndrome, celiac disease, systemic sclerosis,
sicca syndrome
 ANA=IgM
 Genetic association: HLAD8
 Main symptom: Pruritus
 Most common symptom: lethargy
 First line: UDCA
 M2 subtype
 PSC:
 Male+25-40 years of age+lethargy, itching, RUQ pain+ Increase ALP+ P-ANCA
positive+ H/O ulcerative colitis/ IBD/Cholangiocarcinoma+ Hepatosplenomegaly.
 Biopsy: Onion skin fibrosis
 Initial/ key investigation: MRCP
 Cancer screening: Ca gall bladder, colorectal cancer.
 Autoimmune hepatitis:
 Female+ Jaundice+ secondary amenorrhea+ hepatosplenomegaly+ ANA (IgG)
80% positive+ 70% ASMA positive
 Genetic association: HLA D3,4.
 Association: Autoimmune thyroiditis, hypergammaglobunemia
 Liver biopsy (confirmatory): portal lymphoplasmacytic hepatitis, interphase
hepatitis± cirrhosis.
 IgG-4 associated cholangitis:
 Obstructive jaundice+ PSC ± hilar cholangiocarcinoma
 Liver biopsy: Lymphoplasmacytic infiltrate with IgG4-positive plasma cells
 Autoimmune cholangitis: AMA negative PBC.
 NAFLD:
 Obese type II diabetes/ metabolic syndrome+ Abnormal liver function test+
fatigue+ mild RUQ discomfort+ 50-60 years of age
 Initial test: LFT
 Steatosis: Fat infiltration>5%± mild inflammation
 NASH: ALT>AST [Steatosis+ necroinflammation(ballooning, Mallory bodies,
megamitochondria)]
 Cirrhosis: AST>ALT
 Gold standard investigation: Liver biopsy (Perisinusoidal fibrosis)
 3 lesion; Steatosis, hepatocellular injury, inflammation.
 Alcohlic liver disease:
 H/O alcohol for 10/15 years+ features of cirrhosis (Palmar erythema, tender
hepatomegaly, Dupuytren’s contracture, Gynaecomastia, florid telangectasia)+
investigation=Macrocytosis.
 AFLD:
 No hepatomegaly
 AST>ALT
 MCV more increased
 GGT increased
 ALP-Normal
 Good prognosis
 Alcoholic hepatitis:
 Jaundice+ tender hepatomegaly
 (Balloning degeneration of hepatocyte, neutrophil infiltration,Mallory’s hyaline,
pericellular fibrosis)
 DF score (PT+ Bilirubin)>32=poor prognosis
 Mildly elevated ALT, AST/ALT>1.5-2
 Most important collaterals=Esophagus, stomach
 Most important consequence of pulmonary hypertension=Variceal bleeding
 Most common cause of portal HTN=Schistosomiasis
 Most useful investigation of portal HTN=Endoscopy
 Alcoholic cirrhosis=Ascites+ Variceal hemorrhage+ features of cirrhosis (Here
increase risk of HCC)
 Most significant bedside examination of hepatic encephalopathy=Flapping tremor
 Degree of liver damage is assessed by= S. bilirubin.
 Synthetic function of liver best assessed by=Albumin & PT
(Albumin is for chronic liver injury, PT is for acute liver injury+ prognosis of acute and
chronic liver failure)
 Increase AST condition:
 Alcoholic hepatitis
 Drug induced hepatitis
 Liver cirrhosis
 Wilson’s disease (Increase more AST then ALT)
 Increase ALT condition:
 Fatty liver
 Viral hepatitis
 NASH
 Hepatorenal syndrome:

Type I Progressive oliguria+ Rapid rise of S. creatinine+ Poor prognosis+


usually no proteinuria+ Urinary Na<10 mmol/24 hour , Urine/ plasma
osmolarity ratio> 1.5+ Hemodialysis not improve the outcome.
Treatment: Albumin infusion/ IV terlipressin.
Type II Patient with refractory ascites, moderate and stable elevation of S.
creatinine. Better prognosis.
 Hepatopulmonary syndrome:
 Clubbing+ Cynanosis+ Spider naevi+ decrease arterial oxygen saturation+
Orthodeoxia.
 Treatment: Liver transplantation
 Hemochromatosis:
 Age> 40 years+Male+Pituitary disfunction+ Arthralgia/ arthritis+ DM+
hepatomegaly (cirrhosis) with normal LFTs+ Cardiomyopathy+ Increase S.
ferritin and transferrin saturation
 Mutation in HFE gene [C282Y (chromosome 6) and H63D]
 Liver biopsy-Perl’s stain, iron in hepatocyte.
 Initial investigation=Transferrin saturation
 Confirmation=Liver biopsy
 Family member screening=HFE gene
 General member screening=Transferrin saturation> ferritin
 First iron deposition in liver=periportal hepatocyte
 Joint X ray=Chondrocalcinosis
 Leaden Gray skin pigmentation
 Most striking feature=Pigmentation
 Screening test of iron overload (absence of inflammation)=S. ferritin
 Suggestive of secondary iron overload=Accumulation of iron in RE cell.
 Reversible with treatment=Cardiomyopathy and skin pigmentation.
 Malignancy screening=HCC
 Wilson’s disease:
 Young adult+ neuropsychiatric symptoms+ family history of liver disease
 ATP7B, Chromosome 13.
 Changes in body parts:
Liver Recurrent hepatitis
Eye Kayser-Fleischer ring (most important
single clinical clue)
kidney Fanconi’s syndrome
Blood Hemolysis
Brain Chorea, Parkinsonism
 Single best laboratory clue to diagnosis=Low serum ceruloplasmin
 Useful confirmatory test=24 hours urinary copper while giving D-penicillamine
(diagnostic)
 Drug of choice=D-penicillamine
 Alpha1- AD:
 Emphysema+ Jaundice+ Ascites+ Liver biopsy+ PAS positive, diastase-resistant
globules in periportal hepatocyte
 Mutation in Pizz gene
 Gilbert’s syndrome:
 Jaundice specially with fasting+ normal LFT+ Normal Hb/PBF+ Isolated raised
bilirubin+ Inter-current illness+ family history
 Mutation in UGT1A1
 Most common form of non hemolytic hyperbilirubinemia
 Budd Chiari syndrome:
 Sudden abdominal pain+ Tender hepatomegaly+ Ascites+H/O pulmonary
embolism/ pregnancy
 Very sensitive and initial investigation=Doppler ultrasound
 CT=Enlargement of caudate lobe of liver..
 Treatment=Thrombolysis
 Biopsy: Centrilobular congestion with fibrosis
 Gold standard for diagnosis of sphincter of Oddi dysfunction=Sphincter of Oddo
manometry.
 Liver abscess: high grade fever with chills and rigor+ RUQ pain +Jaundice
 HCC: Hepatic rub+ Raised AFP+ Abdominal bruit.
 Ampullary tumour: Obstructive jaundice+ Occult blood test positive
 Most convenient method of demonstrating obstruction to the common bile
duct=Transabdominal USG.
 Hepatitis:
HAV Children mostly affected
HBV HBV DNA most sensitive, Initial test-HBsAg, vertical transmission is
most common here.
HCV Initial test=HCV antibody, more causes cirrhosis
HDV May cause aggressive hepatitis combined with HBV
HEV High mortality in pregnant lady
 Hepatitis:
 Prevented by vaccine=BAD
 Post exposure prophylaxis=ABC
 Transmitted by saliva=ABC
 Sexual transmission=BD, ACE (uncommon)
 Feco-oral route-AE
 Pre-core mutant HBV related hepatitis: HBsAg (+ve)+ HBeAg(+ve)+ Raised HBV
DNA
 Association:
HBV Membranous GN, Polyarteritis nodusa, Lichen planus
HCV Porphyria cutanea tarda, Cryoglobulinemia,Messangio-capillary GN,
Lichen planus
 Liver anatomy:
Structural unit Hepatic lobule
Nutritional unit Portal lobule
Functional/ metabolic unit Hepatic acinus
 Liver biopsy finding:
Alcoholic hepatitis Pericellular fibrosis
NASH Perisinusoidal fibrosis
PSC Periductal onion skin fibrosis
Budd Chiari syndrome Centrilobular fibrosis
Autoimmune hepatitis Interface hepatitis
Alpha 1 AD PAS positive, Diastase resistant globules in periportal
hepatocyte
PBC Granulomatous dysfunction in intrahepatic bile duct
 Cirrhosis of liver with hepatomegaly:
i) Alcoholic cirrhosis
ii) Wilson’s disease
iii) Hemochromatosis
iv) PBC
 Isolated elevation of GGT:
i) Alcohol
ii) NAFLD/ enzyme inducing drug
 Poor prognosis of liver cirrhosis=hyponatremia
 Indicator of impaired liver function: PT
 Poor marker of ongoing alcohol consumption-macrocytosis
 Pyogenic liver abscess:
 Most common organism: S. milleri
 Most common symptom: Abdominal pain
 Confirmatory test: Needle aspiration under USG.
 Usual cause: Biliary obstruction (Cholangitis)
 Main factor thought to be of pathophysiology of CLD=Splanchnic vasodilation
 One of the most important clinical tools for assessment of hepatocyte function=PT
or INR
 First line USG=Gallstone, Biliary obstruction or thrombosis in the hepatic
vasculature.
 Cardinal feature of portal hypertension: Splenomegaly
 Portal HTN:
 Primary or secondary prevention: Beta-blocker (if not tolerated then
prophylactic banding)
 Best suited to the treatment of esophageal varices=Banding
 Cardinal feature of acute liver failure: Hepatic encephalopathy and/ or cerebral
edema
 Best screening test for acute hepatitis B infection=Hepatitis B core IgM antibody
 Poor indicator of the degree of liver fibrosis in hepatitis C=S. transaminase level
 Most common benign liver tumour=Hemangioma
 Most common antibiotic to cause abnormal LFTs=Co-amoxiclav
 Best known drug of hepatocellular necrosis=paracetamol
 Granuloma in liver injury=Allopurinol
 Microvesicular hepatic fat deposition=Tetracycline, sodium valproate
 Macrovesicular hepatic fat deposition=Tamoxifen, amiodarone

You might also like